Viruses in human cancers

European Journal of Cancer

Volumn 35, Issue 14, 1999, Pages 1878-1885

  Zur Hausen, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CARCINOGENESIS; CELL TRANSFORMATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HERPES VIRUS; HUMAN; LYMPHOMA; ONCOVIRINAE; PRIORITY JOURNAL; REVIEW; SEROEPIDEMIOLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS ONCOGENE; WART VIRUS;

EID: 0033391304     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00291-9     Document Type: Article

References (89)

1. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1:1964;702-703.
2. Burkitt D. A children's cancer dependent on climatic factors. Nature. 194:1962;232-234.
3. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt lymphoma. J. Bacteriol. 91:1966;1248-1256.
4. Old L.J., Boyse E., Oettgen H.F.et al. Precipitating antibodies in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc. Nat. Acad. Sci. USA. 56:1966;1699-1704.
5. zur Hausen H., Schulte-Holthausen H., Klein G.et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinoma of the nasopharynx. Nature. 228:1970;1056-1058.
6. zur Hausen H., Schulte-Holthausen H. Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumor cells. Nature. 227:1970;245-248.
7. Blumberg B.S., Gerstley B.J., Hungerford D.A., London W.T., Sutnick A. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann. Intern. Med. 66:1967;924-931.
8. Prince A.M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc. Nat. Acad. Sci. USA. 60:1968;614-621.
9. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus. evidence for a causal association Prog. Med. Virol. 24:1978;40-69.
10. Beasley R.P., Hwang L.Y., Lin C.C., Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 2:1981;1129-1133.
11. Summers J., Smolec J.M., Snyder R. A virus similar to hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Nat. Acad. Sci. USA. 75:1978;4533-4537.
12. Poiesz B.J., Ruscetti F.W., Gazdor A.F.et al. Detection and isolation of type C retrovirus from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Nat. Acad. Sci. USA. 77:1980;7415-7419.
13. Hinuma Y., Nagata K., Hanaoka M. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Nat. Acad. Sci. USA. 78:1981;6476-6480.
14. Jablonska S., Millewski B. Zur Kenntnis der epidermodysplasia verruciformis Lewandowsky-Lutz. Dermatologica. 115:1957;1-22.
15. zur Hausen H., Meinhof W., Scheiber W., Bornkamm G.W. Attempts to detect virus-specific DNA sequences in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus Int. J. Cancer. 13:1974;650-656.
16. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res. 36:1976;530.
17. Dürst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Nat. Acad. Sci. U.S.A. 80:1983;3812-3815.
18. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer and in cell lines derived from genital cancer. EMBO J. 3:1984;1151-1156.
19. Ikenberg H., Gissmann L., Gross G., Grussendorf-Conen E.-I., zur Hausen H. Human papillomavirus type 16 related DNA in genital Bowen's disease and in Bowenoid papulosis. Int. J. Cancer. 32:1983;563-564.
20. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., zur Hausen H. Structure and transcription of human papillomavirus type 18 and 16 sequences in cervical carcinoma cells. Nature. 314:1985;111-114.
21. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
22. Kiyosawa K., Sodeyama T., Tanaka E.et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma. analysis by detection of antibody to hepatitis C virus Hepatology. 12:1990;671-675.
23. Chang Y., Cesarman E., Pessin M.S.et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's soma. Science. 266:1994;1865-1869.
24. Moore P.S., Gao S.J., Dominguez G.et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol. 70:1996;549-558.
25. Gao S.J., Kingsley L., Hoover D.R.et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N. Engl. J. Med. 335:1996;233-241.
26. Evans AS. Viral infections of humans. Epidemiology and control. New York Chapter 1: Epidemiological concepts and methods, Plenum Publishing Corporation, 1976, 1-32.
27. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Topics Microbiol. Immunol. 186:1994;131-156.
28. Yabe Y., Sakai A., Hitsumoto T., Hanafusa H., Jitsumori Y., Ogura H. Human papillomavirus-5b DNA integrated in a metastatic tumor. cloning, nucleotide sequence and genomic organization Int. J. Cancer. 80:1999;334-335.
29. Zahm P., Hofschneider P.H., Koshy R. The HBV X-ORF encodes a transactivator. a potential factor in viral hepatocarcinogenesis Oncogene. 3:1988;169-177.
30. Meyer M., Caselmann W.H., Schlüter V., Schreck R., Hofschneider P.H., Baeuerle P.A. Hepatitis B virus transactivator MHBst. activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization EMBO J. 11:1992;2991-3001.
31. Natoli G, Avantaggiati ML, Balsano C, et al. Characterization of the Hepatitis B virus preS/S region encoded transcriptional transactivator. Virology 1992, 187, 663-670.
32. Moriya K., Fujie H., Shintani Y.et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nature Med. 4:1998;1065-1067.
33. Farrell P.J., Cludts I., Stuhler A. Epstein-Barr virus genes and cancer cells. Biomed. Pharmacother. 51:1997;258-267.
34. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Nat. Acad. Sci. USA. 59:1968;94-101.
35. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1996;2397-2446 Lippincott-Raven, Philadelphia, New York.
36. Thorley-Lawson D.A., Miyashita E.M., Khan G. Trends Microbiol. 4:1996;204-208.
37. Strobl I., Hoefelmayr H., Stein C.et al. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-Jκ Immunobiology. 198:1997;299-306.
38. Sakai T., Taniguchi Y., Tamura K.et al. Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2. J. Virol. 72:1998;6034-6039.
39. Cesarman E., Nador R.G., Bai F.et al. Kaposi's sarcoma-associated herpesvirus contains G-protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70:1996;8218-8223.
40. Neipel F., Albrecht J.C., Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8. determinants of its pathogenicity? J. Virol. 71:1997;4187-4192.
41. Miyoshi I., Yoshimoto S., Kubonishi I.et al. Transformation of normal human cord lymphocytes by co-cultivation with a lethally irradiated human T-cell carrying type C virus. GANN. 72:1981;997-998.
42. Yamamoto Y., Okada M., Koyanagi Y., Kannagi M., Hinuma Y. Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science. 217:1982;737-739.
43. Grassmann R., Dengler C., Müller-Fleckenstein I.et al. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a herpesvirus saimiri vector. Proc. Nat. Acad. Sci. USA. 86:1989;3351-3355.
44. Fujii M., Niki T., Mori T.et al. HTLV-I tax induces expression of various immediate early serum response genes. Oncogene. 6:1991;1023-1029.
45. Fujii M., Tsuchya H., Chuhjo T., Akizawa T., Seiki M. Interaction of HTLV-I tax-1 with p67 (SRF) causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 6:1992;2066-2076.
46. Hawley-Nelson P., Vousden K.H., Hubbert N.L., Lowy D.R., Schiller J.T. HPV 16 E6 and E7 proteins cooperate to immortalise human foreskin keratinocytes. EMBO J. 8:1989;3905-3910.
47. Dyson N., Howley P.M., Münger K., Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
48. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
49. Scheffner M., Werness B.A., Huibregtse J.M., Levine J.M., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
50. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV 16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquination of p53. Cell. 75:1993;495-505.
51. Van de Pol S.B., Brown M.C., Turner C.E. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene. 16:1998;43-52.
52. Ronco L., Karpova A.Y., Vidal M., Howley P.M. The human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:1998;2061-2072.
53. Hennessy K., Kieff E. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc. Nat. Acad. Sci. USA. 80:1983;5665-5669.
54. Shimizu N., Tanabe-Tochikura A., Kuroiwa Y., Takada K. Isolation of Epstein-Barr virus-negative cell clones from the EBV-positive Burkitt's lymphoma line Akata. malignant phenotype of BL cells are dependent on EBV J. Virol. 68:1994;6069-6073.
55. Sayos J., Wu C., Morra M.et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:1998;462-469.
56. de Villiers E.-M. Heterogeneity of the human papillomavirus group. J. Virol. 63:1989;4898-4903.
57. de Villiers E-M. Human Pathogenic Papillomaviruses: An Update. Curr Topics Microbiol Immunol. Berlin-Heidelberg, Springer Verlag, 1994, 86, 1-12.
58. Shah K.V., Howley P.M. Papillomaviruses. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1996;2077-2109 Lippincott-Raven, Philadelphia, New York.
59. Münger K., Phelps W.C., Bubb V., Howley P.M., Schlegel R. The E6 and E7 genes of human papillomavirus type 16 are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:1989;4417-4423.
60. von Knebel Doeberitz M., Rittmüller C., zur Hausen H., Dürst M. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 antisense RNA. Int. J. Cancer. 51:1992;831-834.
61. von Knebel Doeberitz M., Rittmüller C., Aengeneyndt F., Jansen-Dürr P., Spitkovsky D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells. consequences for the phenotype and E6-p53 and E7-pRB interactions J. Virol. 68:1994;2811-2821.
62. Pereira-Smith O.M., Smith J.R. Expression of SV40 antigen in finite lifespan hybrids of normal and SV40-transformed fibroblasts. Somatic Cell Genetics. 7:1981;411-421.
63. Chen T-M., Pecoraro G., Defendi V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53:1993;1167-1171.
64. zur Hausen H. Intracellular surveillance of persisting viral infections. human genital cancer resulting from failing cellular control of papillomavirus gene expression Lancet. 2:1986;489-491.
65. Bosch F., Schwarz E., Boukamp P., Fusenig N.E., Bartsch D., zur Hausen H. Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa-fibroblast hybrid cells. J. Virol. 64:1990;4743-4754.
66. Dürst M., Bosch F.X., Glitz D., Schneider A., zur Hausen H. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV positive human cell lines. J. Virol. 65:1991;796-804.
67. Stoler M.H., Rhodes C.R., Whitbeck A., Wolinsky S.M., Chow L.T., Broker T.R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23:1992;117-128.
68. Dürst M., Glitz D., Schneider A., zur Hausen H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia. analysis by in situ hybridization Virology. 189:1992;132-140.
69. zur Hausen H. Cell-virus gene balance hypothesis of carcinogenesis. Behring Inst. Mitt. 61:1977;23-30.
70. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet. 343:1994;955-957.
71. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochem. Biophys. Acta. Rev. on Cancer. 1288:1996;F55-F78.
72. Reznikoff C.A., Yeager T.R., Belair C.D., Savelieva E., Puthenveettil J.A., Stadler W.M. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human epithelial cells. Cancer Res. 56:1996;2886-2890.
73. Zerfass-Thome K., Zwerschke W., Mannhardt B., Tindle R., Botz J.W., Jansen-Dürr P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene. 13:1996;2323-2330.
74. Funk J.O., Waga S., Harry J.B., Espling E., Stillman B., Galloway D.A. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 protein. Genes Dev. 11:1997;2090-2100.
75. Jones D.L., Alani R.M., Münger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11:1997;2101-2111.
76. Soto U, Das BC, Lengert M, Finzer P, zur Hausen H, Rösl F. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 1999, 18, 3187-3198.
77. Rösl F., Das B.C., Lengert M., Geletneky K., zur Hausen H. Antioxidant-induced changes in AP-1 composition result in a selective suppression of human papillomavirus transcription. J. Virol. 71:1997;362-370.
78. Mantovani A., Bussolino A., Introna M. Cytokine regulation of endothelial cell function. from molecular level to the bedside Immunol. Today. 18:1997;231-240.
79. Goebeler M., Kilian K., Gillitzer R.et al. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-α-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood. 93:1999;857-865.
80. Smits P.H.M., Smits H.L., Minnaar R.et al. The trans-activation of the HPV 16 long control region in human cells with a deletion in the short arm of chromosome 11 is mediated by the 55 kDa regulatory subunit of protein phosphatase 2A. EMBO J. 11:1992;4601-4606.
81. Berkhout R.J.M., Tieben L.M., Smits H.L., Bouwes-Bavinck J.N., Vermeer B.J., ter Schegget J. Detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. a nested approach J. Clin. Microbiol. 33:1995;690-695.
82. Shamanin V., zur Hausen H., Lavergne D.et al. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J. Natl. Cancer Inst. 88:1996;802-811.
83. Kinlén L.J. Infection and childhood leukemia. Cancer Causes Control. 9:1998;237-239.
84. Whittle H.C., Maine N., Pilkinton J.et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet. 345:1995;1089-1092.
85. Chang M.H., Chen C.J., Lai M.S.et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N. Engl. J. Med. 336:1997;1855-1859.
86. Suzich J.A., Ghim S.J., Palmer-Hill F.J.et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Nat. Acad. Sci. US. 92:1995;11553-11557.
87. Breitburd F., Kirnbauer R., Hubbert N.L.et al. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:1995;3959-3963.
88. Campo M.S. Vaccination against papillomavirus in cattle. Clin. Dermatol. 15:1997;275-283.
89. Borysiewicz L.K., Fiander A., Nimako M.et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet. 347:1996;1523-1527.